Su An

727 Jingming South Road
Kunming, 650500, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D-Dependent Regulation of α-Synuclein Homeostasis.

Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D-Dependent Regulation of α-Synuclein Homeostasis.

Journal: Phytotherapy research : PTR

Published: December 05, 2025

Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.

Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.

Journal: Cell communication and signaling : CCS

Published: October 16, 2025

Parishin A alleviates insomnia by regulating hypothalamic-pituitary-adrenal axis homeostasis and directly targeting orexin receptor OX2.

Parishin A alleviates insomnia by regulating hypothalamic-pituitary-adrenal axis homeostasis and directly targeting orexin receptor OX2.

Journal: European journal of pharmacology

Published: November 14, 2024

Activation of the Melatonin Receptor MT1 by the Natural Product Gastrodin to Promote Sleep.

Activation of the Melatonin Receptor MT1 by the Natural Product Gastrodin to Promote Sleep.

Journal: Journal of pineal research

Published: April 10, 2024

Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.

Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.

Journal: Biochemical pharmacology

Published: February 07, 2024

New animal model of chronic gout reproduces pathological features of the disease in humans.

New animal model of chronic gout reproduces pathological features of the disease in humans.

Journal: RMD open

Published: July 15, 2023

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling.

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling.

Journal: Genes

Published: February 27, 2023

Pyroptosis and the fight against lung cancer.

Pyroptosis and the fight against lung cancer.

Journal: Medicinal research reviews

Published: October 06, 2022

Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine.

Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine.

Journal: Chinese journal of integrative medicine

Published: July 11, 2022

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways.

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways.

Journal: Biochemical pharmacology

Published: October 05, 2021

A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer's Disease.

A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer's Disease.

Journal: Frontiers in pharmacology

Published: July 18, 2021

Akt scaffold proteins: the key to controlling specificity of Akt signaling.

Akt scaffold proteins: the key to controlling specificity of Akt signaling.

Journal: American journal of physiology. Cell physiology

Published: June 23, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026